Kenneth Lim

11PUBLICATIONS
52CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCellular immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 12, 2026
Prophylactic dexamethasone at the time of absolute lymphocyte expansion does not mitigate risk or event-free survival for immune effector cell associated delayed neurotoxicity.

|Aug 14, 2026
Review Article: Immune Effector Cell-Mediated Enterocolitis Following CAR-T Cell Therapy-Clinical Features, Pathophysiology and Management.

|Jun 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Apr 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis after ciltacabtagene autoleucel.

Kenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen

|Dec 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.

Kenneth J C Lim, Melinda Tan, Ricardo Parrondo

Pageof 2

Frequent Collaborators

5 joint publications

Rafael Fonseca

5 joint publications

Moritz Binder

5 joint publications

Saurabh Chhabra

5 joint publications

Morie Gertz